feasibility study SDI test evaluation gastrointestinal cancer sensitivity drugs succinic dehydrogenase inhibition SDI test sensitivity cancer cells agents techniques tissue culture ability formazan use methylthiazol tetrazolium bromide MTT triphenyl tetrazolium chloride TTC assay SDI test order drug response gastrointestinal cancer clinical study assay optimal concentration levels mytomycin-C Adriamycin clinical materials micrograms/ml times cancer cell line Cisplatin micrograms/ml Cisplatin unstable culture medium antitumor effect necessary cancer cells days assay clinical materials evaluable rate assay peculiarity assay high evaluable rate results test useful clinical application 